Satellos Bioscience Inc. (MSCLF)
USD 0.48
(-4.42%)
USD 0.48
(-4.42%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -15.45 Million CAD | -91.53% |
| 2022 | -8.09 Million CAD | -76.54% |
| 2021 | -4.6 Million CAD | -195.89% |
| 2020 | -1.54 Million CAD | 29.86% |
| 2019 | -1.99 Million CAD | -0.11% |
| 2018 | -2.2 Million CAD | -51.75% |
| 2017 | -1.44 Million CAD | -20.45% |
| 2016 | -1.2 Million CAD | 45.03% |
| 2015 | -2.18 Million CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -7.81 Million CAD | -25.06% |
| 2024 Q2 | -6.31 Million CAD | 22.76% |
| 2023 Q2 | -2.8 Million CAD | -69.49% |
| 2023 FY | - CAD | -91.53% |
| 2023 Q3 | -3.94 Million CAD | -40.36% |
| 2023 Q1 | -1.65 Million CAD | 25.68% |
| 2023 Q4 | -5.71 Million CAD | -44.85% |
| 2022 Q1 | -2.01 Million CAD | -41.09% |
| 2022 FY | - CAD | -76.54% |
| 2022 Q4 | -2.23 Million CAD | -29.18% |
| 2022 Q3 | -1.72 Million CAD | 17.81% |
| 2022 Q2 | -2.1 Million CAD | -4.42% |
| 2021 Q3 | -1.46 Million CAD | -190.47% |
| 2021 Q1 | -856.32 Thousand CAD | -60.28% |
| 2021 Q2 | -504.35 Thousand CAD | 41.1% |
| 2021 FY | - CAD | -195.89% |
| 2021 Q4 | -1.42 Million CAD | 2.67% |
| 2020 Q4 | -534.25 Thousand CAD | -81.52% |
| 2020 Q3 | -294.31 Thousand CAD | 9.71% |
| 2020 Q2 | -325.98 Thousand CAD | 48.48% |
| 2020 Q1 | -632.76 Thousand CAD | 0.0% |
| 2020 FY | - CAD | 29.86% |
| 2019 FY | - CAD | -0.11% |
| 2018 FY | - CAD | -51.75% |
| 2017 FY | - CAD | -20.45% |
| 2016 FY | - CAD | 45.03% |
| 2015 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Evofem Biosciences, Inc. | -17.37 Million USD | 11.019% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -297.907% |
| CSL Limited | 4.78 Billion USD | 100.323% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 116.436% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -1549.61% |
| BioStem Technologies, Inc. | -7.55 Million USD | -104.616% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -783.201% |
| Qrons Inc. | -40.08 Thousand USD | -38461.912% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 3030.42% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 72.07% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -115.827% |
| Skye Bioscience, Inc. | -13.54 Million USD | -14.087% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -4108.91% |
| Rebus Holdings, Inc. | -951 Thousand USD | -1525.237% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 2.607% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Genscript Biotech Corporation | -248.71 Million USD | 93.786% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -2344.0% |
| Adynxx, Inc. | - USD | Infinity% |
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 78.242% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -160.689% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -6362.889% |
| SQZ Biotechnologies Company | -64.14 Million USD | 75.903% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -484.47% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -906.218% |
| Mesoblast Limited | -62.38 Million USD | 75.227% |
| Marizyme, Inc. | -34.28 Million USD | 54.914% |
| Genus plc | 73.7 Million USD | 120.972% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -133.774% |
| Pharming Group N.V. | 9.87 Million USD | 256.485% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -939.12% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -335.749% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -76.197% |
| ContraFect Corporation | -64.99 Million USD | 76.221% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -241.479% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -1002.576% |
| IMV Inc. | -35.52 Million USD | 56.491% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -565.112% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -2883.519% |
| ONE Bio Corp. | 13.61 Million USD | 213.538% |
| Accustem Sciences Inc. | -3.74 Million USD | -312.554% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 67.952% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -1119.762% |
| Q BioMed Inc. | -617.62 Thousand USD | -2402.477% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 532.699% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -576.563% |
| Biomind Labs Inc. | -1.03 Million USD | -1393.984% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 61.006% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -434.38% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 229963.177% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -61724.0% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -517.755% |
| GB Sciences, Inc. | -1.41 Million USD | -988.539% |
| Alpha Cognition Inc. | -9.7 Million USD | -59.248% |
| HST Global, Inc. | -5303.00 USD | -291357.665% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -651.386% |
| Halberd Corporation | -74.27 Thousand USD | -20708.035% |
| Enzolytics Inc. | -2.12 Million USD | -628.36% |
| Agentix Corp. | -1.37 Million USD | -1026.731% |
| Resverlogix Corp. | -11.74 Million USD | -31.63% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -404.601% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -216.02 Million USD | 92.845% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 1370.008% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 274.569% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -931.152% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 4179.78% |
| AVAX Technologies, Inc. | -6.11 Million USD | -152.853% |
| Zenith Capital Corp. | -8.6 Million USD | -79.596% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -88620.51% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -531.77% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -8680.603% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -704.618% |
| Kadimastem Ltd | -2.62 Million USD | -488.939% |
| Helix BioMedix, Inc. | -1.04 Million USD | -1377.188% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -8435.077% |
| LadRx Corporation | 412.28 Thousand USD | 3848.881% |
| Cell Source, Inc. | -4.27 Million USD | -261.753% |
| Regen BioPharma, Inc. | 1.46 Million USD | 1154.329% |
| NovAccess Global Inc. | -1.03 Million USD | -1393.626% |
| Affymax, Inc. | -14.29 Million USD | -8.122% |
| Itoco Inc. | -1.86 Million USD | -726.969% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -3971.44% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -1284.946% |
| Mobile Lads Corp. | -2.24 Million USD | -589.643% |
| CytoDyn Inc. | -18.02 Million USD | 14.271% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -19457.378% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -126288.094% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -3082.355% |
| SYBLEU INC | -141.57 Thousand USD | -10817.49% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -1355.354% |
| International Stem Cell Corporation | 202 Thousand USD | 7751.485% |
| Bioxytran, Inc. | -3.82 Million USD | -304.592% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -29261.702% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -527.8% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 56.91% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -34246.667% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -464.5% |
| Neutra Corp. | -181.24 Thousand USD | -8427.589% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 23.33% |
| PureTech Health plc | -11.62 Million USD | -32.932% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 23.324% |
| IXICO plc | -707 Thousand USD | -2086.139% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -101.119% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 68.03% |
| CSL Limited | 4.73 Billion USD | 100.327% |
| Cellectis S.A. | -92.63 Million USD | 83.315% |